首页|期刊导航|老年心脏病学杂志(英文版)|Clinical profile and outcomes in very elderly patients with at-rial fibrillation anticoagulated with rivaroxaban:data from the EMIR study
Clinical profile and outcomes in very elderly patients with at-rial fibrillation anticoagulated with rivaroxaban:data from the EMIR study
Francisco Marín Carles Rafols Priu Esteban Orenes-Piñero María Asunción Es-teve-Pastor Manuel Anguita Sánchez Iñaki Lekuona Marcelo Sanmartín Fernán-dez Vivencio Barrios Carlos Perez Muñoz Juan Cosín-Sales Alejandro I.Pérez Cabeza Vanesa Roldán Schilling
老年心脏病学杂志(英文版)2024,Vol.21Issue(7):723-732,10.
老年心脏病学杂志(英文版)2024,Vol.21Issue(7):723-732,10.DOI:10.26599/1671-5411.2024.07.003
Clinical profile and outcomes in very elderly patients with at-rial fibrillation anticoagulated with rivaroxaban:data from the EMIR study
Clinical profile and outcomes in very elderly patients with at-rial fibrillation anticoagulated with rivaroxaban:data from the EMIR study
摘要
引用本文复制引用
Francisco Marín,Carles Rafols Priu,Esteban Orenes-Piñero,María Asunción Es-teve-Pastor,Manuel Anguita Sánchez,Iñaki Lekuona,Marcelo Sanmartín Fernán-dez,Vivencio Barrios,Carlos Perez Muñoz,Juan Cosín-Sales,Alejandro I.Pérez Cabeza,Vanesa Roldán Schilling..Clinical profile and outcomes in very elderly patients with at-rial fibrillation anticoagulated with rivaroxaban:data from the EMIR study[J].老年心脏病学杂志(英文版),2024,21(7):723-732,10.基金项目
Writing and editorial assistance was provided by Content Ed Net(Madrid,Spain)with funding from Bayer Hispania. EMIR Study is sponsored by Bayer. (Madrid,Spain)